What actually happens between your idea and your first pallet

Most people approaching a contract manufacturer for the first time imagine one step: you send a formula, the factory makes it. In practice there are six, and the two that hold up timelines are not the ones anyone expects.

Here is the actual sequence.

1. Formulation review — before anything is priced

The first conversation is not commercial. It is technical.

At Organix, any client arriving with a product sits with someone from R&D before anything else happens. The question that session answers is narrow and important: is this formula manufacturable here, at this scale, on this equipment, without problems?

That question has teeth. A formula that works in a lab beaker can fail on a tablet press. An ingredient can be hygroscopic enough to seize a sachet line. A blend can separate. Some raw materials are difficult enough that factories decline them outright — waxy materials, for instance, are notoriously hard to process and more than one plant will simply pass on them.

Finding this out in week one costs a conversation. Finding it out in month three costs a production run.

If you do not have a formula yet, this is also where one gets built. R&D can develop from a brief — target consumer, claim, dosage form, price point — or adapt an existing formula to suit a different market or a different regulator.

2. The sample

Next comes a physical sample, made and sent to you.

This stage is less about proving the factory can produce and more about aligning expectations that words cannot carry. Taste, smell, mouthfeel, how a powder disperses, what a capsule actually looks like in a hand, whether a syrup is the colour you pictured. These are not specifications. They are judgements, and they need an object.

3. The trial batch — and who pays for it

This is the stage that separates manufacturers, and it is worth asking about directly.

Our chairman describes the approach in two phases. First, the factory runs the product at its own cost, to test itself. Then, once it is satisfied, it runs the product jointly with the client — the plant effectively closed around that one product — to see whether it holds up under real conditions.

"Before I hand the product to you, I was doing work at my own expense. I test myself first, before I tell you come and take the product."

Early in the company's life, he has said, these trial runs lost money. They were treated as a cost of being trusted rather than a line to be recovered.

The practical lesson for a brand owner: ask who pays for the trial, and ask what happens if it fails. The answer tells you how a manufacturer thinks about risk.

4. Registration — the stage that is not in the factory's hands

Here is where most timelines actually slip, and it is worth being blunt: registration is usually slower than manufacturing.

In Egypt, dietary supplements go through a notification and registration process with the National Food Safety Authority. A manufacturer on the NFSA White List can produce; a product still needs its own clearance before it can be sold or exported.

How slow? One client exporting to Sierra Leone spent five months in Egypt waiting for a registration to clear. While waiting, he sent our chairman photographs of a container of the same product — manufactured in Turkey, already shipped.

That story is not an indictment of any one agency. It is a planning fact. If you are building a launch calendar, put registration on the critical path, start it early, and do not assume manufacturing is the long pole. It usually is not.

5. Production

Only now does the factory run your batch.

What happens here depends on dosage form, but the structure is constant: raw materials are tested on arrival, the blend is prepared and checked, the batch is produced, and in-process controls run during the run rather than after it.

That last point matters more than it sounds. An in-process control laboratory exists so that a deviation is caught at the moment it happens, not discovered in a finished-goods sample three days later when the whole batch is already made. The difference between those two scenarios is the difference between adjusting a machine and scrapping a run.

6. Release, and what goes on the pack

A batch is not finished when it is made. It is finished when quality releases it.

One structural detail worth asking any manufacturer about: who can overrule whom. At Organix the quality department outranks the owner on quality decisions, deliberately and publicly. The arrangement was set up on day one, framed by the chairman as a trade: full authority to the quality team, in exchange for zero defects.

Finally, note what will be printed on your pack. Egyptian law requires the manufacturing facility's name to appear on every product it makes. Your brand will not be alone on the label — the factory's name sits alongside it. Most of our clients treat that as a feature rather than a cost, which is only true if you have chosen the factory carefully.

So what actually controls your timeline?

Not the production run. In order of how much they typically cost you:

Registration and regulatory clearance — months, and largely outside the factory's control
Formulation and trial iterations — weeks, and reducible by arriving with a clear brief
Packaging sourcing — weeks, and frequently underestimated
The production run itself — usually the shortest stage

If a manufacturer quotes you a timeline that treats production as the long pole, they are either not accounting for registration or not telling you about it.

Before you send your first enquiry

Have these ready and you will cut weeks off the front end:

The dosage form you want, or a description of how the consumer should take it
A formula if you have one, or a clear brief if you do not
Target market and target consumer — this determines the regulatory path
Your packaging intent, even roughly
Realistic volumes, including what you expect in month twelve, not just month one

The last one gets skipped most often and matters most. A manufacturer quoting for 5,000 units plans differently than one quoting for a line you intend to grow.